Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Akari Therapeutics PLC AKTX

Healthcare Biotechnology
Akari Therapeutics, Plc is a biotechnology company developing advanced therapies for autoimmune and inflammatory diseases. The Company is engaged in the development of antibody drug conjugates (ADCs) and advanced therapies for autoimmune and inflammatory diseases, including geographic atrophy (GA). Its lead asset, investigational nomacopan, is a bispecific recombinant inhibitor of complement C5... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:AKTX)

Akari Therapeutics Announces $7.6 Million Private Placement Offering Led by Existing Shareholders and Insiders Priced at the Market Under Nasdaq Rules

GlobeNewswire 12 days ago

Akari Therapeutics Participates in the Virtual Investor "Top 5 for '25" On-Demand Conference

GlobeNewswire February 19, 2025

Akari Therapeutics Joins Webull Corporate Connect Service Platform

GlobeNewswire February 3, 2025

Akari Therapeutics Announces Key Leadership Appointments

GlobeNewswire December 18, 2024

Akari Therapeutics Appoints Torsten Hombeck, Ph.D. as Chief Financial Officer

GlobeNewswire December 16, 2024

Akari Therapeutics Regains Full Nasdaq Compliance

GlobeNewswire November 19, 2024

Akari Therapeutics Announces Successful Completion of Merger of Akari Therapeutics and Peak Bio

GlobeNewswire November 14, 2024

Akari Therapeutics Announces Shareholder Approval in Connection With Peak Bio, Inc. Merger

GlobeNewswire November 8, 2024

Akari Therapeutics Announces Effectiveness of Form S-4 and General Meeting Date of November 7, 2024 Related to Peak Bio Merger

GlobeNewswire October 15, 2024
View More News ››

Opinion & Analysis (NDAQ:AKTX)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:AKTX)

Akari Therapeutics Receives Positive and Constructive Pre-IN

Just In: $AKTX Akari Therapeutics Receives Positive and Constructive Pre-IND Feedback from US FDA for PAS-nomacopan in Treatment of...
whytestocks - August 19, 2024

Akari Therapeutics and Peak Bio Announce Portfolio Prioritiz

NEWS: $AKTX Akari Therapeutics and Peak Bio Announce Portfolio Prioritization Plan for Combined Go-Forward Merger EntityPrioritization...
whytestocks - May 1, 2024

Excellent YT coverage on Akari!

https://youtu.be/KTwztpoUB1I?si=mRfnI9EC3bYyiNxt
BryceCanada - November 6, 2023

RE:Rumour Mill Whispers..

http://investor.akaritx.com/static-files/50c90eba-430c-4e52-b500-9462bb00ada8
InsideTweeter - December 11, 2021

Rumour Mill Whispers..

Watch this..!!  Market cap $75M - Robust Pipeline - Acquisition value of similar companies in complement space with similar...
InsideTweeter - December 11, 2021

it's a buy today for me

at $4.25 per share,so glta.
coolfooldumbguy - April 23, 2019
View more Bullboard ››

JZR Gold Inc.

JZR Gold Inc.

JZR Gold Inc. is a Canada-based junior mining resource company. The Company is engaged in the business of the exploration and ...
View More »